Mouse IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT655-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Guohong Ge Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine PLoS One 2012 7 e41573
Chun Wang Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B Clin Dev Immunol 2012 2012 563838
Hongxia Niu Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX Vaccine 2011 29 9451-8
Dongrui Deng The preparation of human papillomavirus type 58 vaccine and exploring its biological activity and immunogenicity in vitro Int J Gynecol Cancer 2011 21 988-95
Bin Xie The effects of publishing emergency department wait time on patient utilization patterns in a community with two emergency department sites: a retrospective, quasi-experiment design Int J Emerg Med 2011 4 29
Shanfeng Li Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses Vaccine 2011 29 3695-702
Guimei Yang A synthetic multi-epitope antigen enhances hepatitis C virus-specific B- and T-cell responses Viral Immunol 2011 24 109-18
Mengcheng Luo The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice Vaccine 2011 29 2561-7
Quan-Yi Guo Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma J Exp Clin Cancer Res 2011 30 24
Xiaohong Jiang Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs Vaccine 2011 29 1248-57